| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/23/2004 | US20040185452 Identification of single nucleotide polymorphisms |
| 09/23/2004 | US20040185451 by determining an unlabeled nucleic acid which should be used with an in situ synthesized nucleic acid array to preferentially bind incomplete sequences adjacent array features |
| 09/23/2004 | US20040185447 Dye compositions which provide enhanced differential fluorescence and light scatter characteristics |
| 09/23/2004 | US20040185446 includes escherichia, salmonella, campylobacter, staphyococcus, clostridium, pseudomonas, bifidobacterium, bacillus, enterococcus, aspergillus, candida, saccharomyces; produces fluorescence resonance energy transfer |
| 09/23/2004 | US20040185445 which are two dimensional; for drug screening by performing an indirect competitive binding assay |
| 09/23/2004 | US20040185444 based on gene over/underexpression from biopsy samples; microarrays |
| 09/23/2004 | US20040185443 Analyte-specific assays based on formation of a replicase substrate |
| 09/23/2004 | US20040185439 using polymorphisms to determine susceptibility cancer, osteoporosis, cardiovascular disorders; for drug screening |
| 09/23/2004 | US20040185438 for determining a proper course of treatment, irradication, and/or containment of the bioagent in such cases as biological warfare; bioinformatics |
| 09/23/2004 | US20040185437 Device and method for concentrating and detecting pathogenic microbes from blood products and/or their derivatives |
| 09/23/2004 | US20040185435 Molecular sequence of swine retrovirus and methods of use |
| 09/23/2004 | US20040185434 before, during, or after processing into feed; uses solid phase synthesis, histological analysis, immunological analysis, genetic fingerprinting and ribosomal genotyping |
| 09/23/2004 | US20040185431 for drug screening anticancer agents using animal model expression profiles; genetic engineering |
| 09/23/2004 | US20040185430 Process for evaluating the cosmetic or dermatological activity of a product and use of plant material |
| 09/23/2004 | US20040185429 Method for discovering neurogenic agents |
| 09/23/2004 | US20040185082 Process for producing a film for controlling the chemotactic function and an artificial material and process for producing the artificial material |
| 09/23/2004 | US20040185048 Modulation of IL-2- and IL-15-mediated T cell responses |
| 09/23/2004 | US20040185042 method for highly selective removal of anti-vWF-cp-abs from human plasma using adsorbent comprises hvWF-cp or fragments thereof, coupled to an inert matrix material |
| 09/23/2004 | US20040185037 Human E3alpha ubiquitin ligase family |
| 09/23/2004 | US20040185033 Tumor antigens and CTL clones isolated by a novel procedure |
| 09/23/2004 | US20040184990 Receptor binding conjugates |
| 09/23/2004 | US20040182719 Preparing an aqueous solution for electrochemical polymerisation, assembling an electrochemical polymerisation cell, coating electrodes with polymer film by applying a cyclic voltage, applying a constant current, applying a constant potential |
| 09/23/2004 | US20040182703 Systems and methods for blood glucose sensing |
| 09/23/2004 | DE20221001U1 Housing for a stack of small capacity reaction vessels, comprises chambers to take the vessels in a positive fit across the stacked direction, where the vessels have upper openings which can be accessed by a pipette |
| 09/23/2004 | DE10311984A1 Using neutral endopeptidase-associated molecules for treatment, diagnosis, prophylaxis and monitoring of eating and metabolic disorders and dementia, also for drug development |
| 09/23/2004 | DE10309866A1 Screening compounds for antifungal activity, particularly against Candida albicans, from their ability to alter expression or activity of fungal homologs of the Wiskott-Aldrich syndrome protein |
| 09/23/2004 | DE10262050A1 Genetische Varianten im MMP-2 Gen als ätiologische Faktoren verschiedener Erkrankungen Genetic variants in the MMP-2 gene as etiological factors of various diseases |
| 09/23/2004 | DE10256898A1 Simultaneous detection of many target nucleic acids, useful e.g. for detecting pathogenic microorganisms in water or food, by hybridization with specific oligonucleotides all having the same detection sequence |
| 09/23/2004 | DE10012540B4 Oligonukleotide und Verfahren zum spezifischen Nachweis von Mikroorganismen durch Polymerase-Kettenreaktion Oligonucleotides and methods for the specific detection of micro-organisms by the polymerase chain reaction |
| 09/23/2004 | CA2535777A1 Method and apparatus for pattern identification in diploid dna sequence data |
| 09/23/2004 | CA2519499A1 Phosphokinase assay |
| 09/23/2004 | CA2518957A1 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | CA2518956A1 Single nucleotide polymorphisms associated with stenosis, methods of detection and uses thereof |
| 09/23/2004 | CA2518912A1 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518904A1 Molecular haplotyping of genomic dna |
| 09/23/2004 | CA2518898A1 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | CA2518814A1 Approaches to identifying genetic traits in animals |
| 09/23/2004 | CA2518787A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | CA2518761A1 Use of the genes leprotl1 and ob-rgrp for the screening of active compounds for weight gain or loss or diabetes in human or animal subjects |
| 09/23/2004 | CA2518733A1 Production of plants with improved digestibility having an inactive peroxidase |
| 09/23/2004 | CA2518499A1 Ligand analysis |
| 09/23/2004 | CA2518475A1 Irna agents comprising asymmetrical modifications |
| 09/23/2004 | CA2518452A1 Reca-assisted allele specific oligonucleotide extension method for detecting mutations, snps and specific sequences |
| 09/23/2004 | CA2518423A1 Nucleic acid biosensors |
| 09/23/2004 | CA2518058A1 Diagnostic and prognostic compounds and method |
| 09/23/2004 | CA2516311A1 Methods of evaluating caloric restriction and identifying caloric restriction mimetics |
| 09/23/2004 | CA2516306A1 Compositions and methods for polynucleotide sequence detection |
| 09/22/2004 | EP1460427A1 Method for detection of contaminants |
| 09/22/2004 | EP1460424A2 Biochemical analysis unit |
| 09/22/2004 | EP1460423A1 Three-dimensional colorimetric assay assemblies |
| 09/22/2004 | EP1460136A1 Methods for detecting the presence of a nucleic acid analyte in a sample |
| 09/22/2004 | EP1460135A1 Acetylcholinesterase method to detect organophosphorate and carbamate insecticides in water, foods and beverages |
| 09/22/2004 | EP1460130A1 Potentiometric dna microarray, process for producing the same and method of analyzing nucleic acid |
| 09/22/2004 | EP1460126A2 Microorganisms sampling method and microorganism sampling device |
| 09/22/2004 | EP1460086A1 Process for producing an article containing a film for controlling the chemotactic function and an artificial material obtainable by said process |
| 09/22/2004 | EP1460083A1 High density immobilization of nucleic acids |
| 09/22/2004 | EP1459756A1 REMOVAL PROMOTERS AND INHIBITOR FOR APOPTOSIS CELLS i IN VIVO /i |
| 09/22/2004 | EP1459075A1 Normalisation of microarray data based on hybridisation with an internal reference |
| 09/22/2004 | EP1459073A2 Method for determining molecule-molecule interaction in proteomics |
| 09/22/2004 | EP1459070A2 Methods for diagnosis and treatment of epithelial-derived cancers, such as colorectal cancers and kidney cancers |
| 09/22/2004 | EP1459065A2 Processes for the measurement of the potency of glatiramer acetate |
| 09/22/2004 | EP1459064A2 Test strip for determining concentration of triglycerides |
| 09/22/2004 | EP1459063A2 Screening method for compounds that modulate neuronal activity |
| 09/22/2004 | EP1458894A2 Method for the detection and/or identification of the original animal species in animal matter contained in a sample |
| 09/22/2004 | EP1458893A2 Method and nucleic acids for the analysis of a lung cell proliferative disorder |
| 09/22/2004 | EP1458892A2 Evanescence-based multiplex sequencing method |
| 09/22/2004 | EP1458891A2 Method for analysing hereditary masculine infertility |
| 09/22/2004 | EP1458890A2 Sequencing on perforated membranes |
| 09/22/2004 | EP1458889A2 Discrimination and detection of target nucleotide sequences using mass spectrometry |
| 09/22/2004 | EP1458888A2 Methods of treating psychosis and schizophrenia based on polymorphisms in the cntf gene |
| 09/22/2004 | EP1458887A2 HIGH RESOLUTION TYPING SYSTEM FOR PATHOGENIC $i(E. COLI) |
| 09/22/2004 | EP1458886A2 Tripartite molecular beaconsns |
| 09/22/2004 | EP1458885A2 The use of histamine h4 receptor antagonist for the treatment of inflammatory response |
| 09/22/2004 | EP1458884A1 Method of screening for potential anti-bacterial agents |
| 09/22/2004 | EP1458883A2 Screening method for agents useful in treating diabetes |
| 09/22/2004 | EP1458880A1 Isolation tool for viable c-kit expressing cells |
| 09/22/2004 | EP1458874A2 Method for modifying plant morphology, biochemistry and physiology comprising expression of plant cytokinin oxidase |
| 09/22/2004 | EP1458868A2 Genes and proteins involved in the biosynthesis of lipopeptides |
| 09/22/2004 | EP1458867A2 Gene promoters |
| 09/22/2004 | EP1458865A2 Human vanilloid receptor protein and polynucleotide sequence encoding same |
| 09/22/2004 | EP1458863A1 A system for stable expression of sirnas in mammalian cells |
| 09/22/2004 | EP1458858A2 Histone h3 methyltransferase polypeptide |
| 09/22/2004 | EP1458857A1 Hxhv virus, nucleic material, peptide material and uses |
| 09/22/2004 | EP1458854A2 Cellular compositions and methods of making and using them |
| 09/22/2004 | EP1458853A2 Methods of donor specific crossmatching |
| 09/22/2004 | EP1458755A2 Novel g-protein coupled receptors and dna sequences thereof |
| 09/22/2004 | EP1458754A2 Novel death associated proteins of the thap family and related par4 pathways involved in apoptosis control |
| 09/22/2004 | EP1458749A2 Bone polypeptide-1 |
| 09/22/2004 | EP1458740A2 Nucleic acid labeling by thermoanaerobacter thermohydrosulfuricus dna polymerase i variants |
| 09/22/2004 | EP1458738A2 Thermus oshimai nucleic acid polymerases |
| 09/22/2004 | EP1458456A2 System, method and apparatus for the rapid detection and analysis of airborne biological agents |
| 09/22/2004 | EP1458410A2 Stabilised mrna tumour vaccine |
| 09/22/2004 | EP1458409A2 14081, a human trypsin-like serine protease family member and uses therefor |
| 09/22/2004 | EP1458404A1 Polyphenol inhibition of nucleoside diphosphate kinase-b activity and cancer metastasis |
| 09/22/2004 | EP1458403A2 Compositions and methods for the treatment and clinical remission of psoriasis |
| 09/22/2004 | EP1409713A4 ASSAY FOR MEASURING FACTOR VIIa-ANTITHROMBIN COMPLEXES |
| 09/22/2004 | EP1350104A4 Presenilin enhancers |
| 09/22/2004 | EP1337546A4 Method for detecting hematopoietic stem cells |
| 09/22/2004 | EP1294944A4 Detection of nucleic acids by type-specific hybrid capture method |
| 09/22/2004 | EP1243658B1 Method of measuring deacetylase activity and method of screening inhibitor or promoter of these enzymes |